Please use this identifier to cite or link to this item:
|Title:||Novel optineurin frameshift insertion in a family with frontotemporal dementia and parkinsonism without amyotrophic lateral sclerosis||Authors:||Dominguez, Jacqueline
Yu, Jeryl Tan
Tan, Jayne Yi
De Guzman, Ma Fe
Daroy, Ma Luisa
Lian, Michelle Mulan
Lim, Weng Khong
Foo, Jia Nee
Ng, Adeline S. L.
|Keywords:||Science::Medicine||Issue Date:||2021||Source:||Dominguez, J., Yu, J. T., Tan, J. Y., Ng, A., De Guzman, M. F., Natividad, B., Daroy, M. L., Cano, J., Yu, J., Lian, M. M., Zeng, L., Lim, W. K., Foo, J. N. & Ng, A. S. L. (2021). Novel optineurin frameshift insertion in a family with frontotemporal dementia and parkinsonism without amyotrophic lateral sclerosis. Frontiers in Neurology, 12, 645913-. https://dx.doi.org/10.3389/fneur.2021.645913||Project:||NRF-NRFF2016-03
|Journal:||Frontiers in Neurology||Abstract:||Frontotemporal Dementia (FTD) is a common cause of Young Onset Dementia and has diverse clinical manifestations involving behavior, executive function, language and motor function, including parkinsonism. Up to 50% of FTD patients report a positive family history, supporting a strong genetic basis, particularly in cases with both FTD and amyotrophic lateral sclerosis (FTD-ALS). Mutations in three genes are associated with the majority of familial FTD (fFTD) cases - microtubule associated protein tau gene (MAPT), granulin precursor (GRN), and hexanucleotide repeat expansions in chromosome 9 open reading frame 72- SMCR8complex subunit (C9orf72) while mutations in other genes such as optineurin (OPTN) have rarely been reported. Mutations in OPTN have been reported mostly in familial and sporadic cases of ALS, or in rare cases of FTD-ALS, but not in association with pure or predominant FTD and/or parkinsonian phenotype. Here, we report for the first time, a family from the Philippines with four members harboring a novel frameshift insertion at OPTN (Chr 10:13166090 G>GA) p.Lys328GluTer11, three of whom presented with FTD-related phenotypes. Additionally, one sibling heterozygous for the frameshift insertion had a predominantly parkinsonian phenotype resembling corticobasal syndrome, but it remains to be determined if this phenotype is related to the frameshift insertion. Notably, none of the affected members showed any evidence of motor neuron disease or ALS at the time of writing, both clinically and on electrophysiological testing, expanding the phenotypic spectrum of OPTN mutations. Close follow-up of mutation carriers for the development of new clinical features and wider investigation of additional family members with further genetic analyses will be conducted to investigate the possibility of other genetic modifiers in this family which could explain phenotypic heterogeneity.||URI:||https://hdl.handle.net/10356/152052||ISSN:||1664-2295||DOI:||10.3389/fneur.2021.645913||Rights:||© 2021 Dominguez, Yu, Tan, Ng, De Guzman, Natividad, Daroy, Cano, Yu, Lian, Zeng, Lim, Foo and Ng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.||Fulltext Permission:||open||Fulltext Availability:||With Fulltext|
|Appears in Collections:||LKCMedicine Journal Articles|
Updated on Jan 25, 2022
Updated on Jan 25, 2022
Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.